AMMI Canada received funding from the Public Health Agency of Canada to develop national antimicrobial prescribing guidelines for the empiric treatment of common infectious syndromes, an initiative for progress on the Pan Canadian Action Plan on Antimicrobial Resistance 2023-2027. This project is a key step forward in ensuring judicious use of antibiotics under the Stewardship pillar where prescribers and other professionals have the resources to facilitate appropriate antimicrobial use (1) .
AMMI Canada is using a robust methodological framework reviewing systematic reviews and meta-analyses and evaluating the quality of evidence using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. A GRADE evidence to Decision frameworks for the adoption, adaptation, and de novo development (GRADE-ADOLOPMENT) (2) of the WHO’s essential medicines and Aware recommendations (3, 4) and other guidelines is applied. The pan-Canadian panel includes infectious disease physicians, medical microbiologists, pharmacists, family physicians, public health and preventive medicine specialists, pediatricians, and methodologists.
For more information on the methodology click on the AMMI Canada Antibiotic Guidelines Methods Summary
This initial release focuses on respiratory tract infections. By downloading the guidance now, clinicians can begin adopting best practices to support more effective care for our patients and communities. Additional treatment guidance for other syndromes will be added over time, building on this foundation to promote consistent, evidence-based antibiotic prescribing across Canada.
To support the dissemination and uptake of the Canadian Antibiotic Treatment Guidance (CATG), we are pleased to offer a collection of ready-to-use graphics and images. This toolkit has been designed to help clinicians, organizations, and partners easily share key messages and promote evidence-based antibiotic use.
All materials are available for download and may be used across presentations, social media, websites, and educational resources. We encourage you to use and share these assets widely to help advance antimicrobial stewardship and support best practices across Canada.
Canadian Antibiotic Treatment Guidance – Communication Toolkit
From Evidence to Action:
Initial Launch of the Canadian Antibiotic Treatment Guidance
Date:
Moderator:
Kanchana Amaratunga, MD, MPH, FRCPC
Infectious Diseases/Public Health Medical Advisor
Public Health Agency of Canada
Presenter:
Deborah Yamamura, BSc, MD, FRCPC
Chair, AMMI Canada Guideline Development Panel
Professor, Department of Pathology and Molecular Medicine
McMaster University, Hamilton, ON
Dena Zeraatkar, MSc, PhD
Co-Chair/Senior Methodologist, AMMI Canada Guideline Development Panel
McMaster University, Hamilton, ON
Michael Long, PhD
Chief Clinical Officer
Firstline
By the end of this webinar participants will be able to:
BSc, MD, FRCPC, Chair
Discipline:
Medical Microbiology and Adult Infectious Diseases
MSc, PhD Co-Chair/Senior Methodologist
Discipline:
Research and Guideline Methodology
Discipline:
Adult Infectious Diseases, Antimicrobial Stewardship, Infection Prevention & Control
University of British Columbia
MD, MSc, FRCPC, DTM+H
Discipline:
Adult Infectious Diseases
Memorial University
St. John’s, NL
BSc(Pharm), PharmD, MPH
Discipline:
Pharmacist, Antimicrobial Resistance and Stewardship
Public Health Ontario and McMaster University
Toronto, ON
BSc(Pharm), PharmD, ACPR, FCSHP
Discipline:
Pharmacist, Infectious Diseases & Antimicrobial Stewardship
University of British Columbia
Vancouver, BC
MD, FRCPC
Discipline:
Paediatric and Adult Infectious Disease, Antimicrobial Stewardship
University of Ottawa
Ottawa, ON
MSc, MD, FRCPC, FIDSA, FRSC
Discipline:
Medical Microbiology and Adult Infectious Diseases
McMaster University
Hamilton, ON
Discipline:
Medical microbiologist and Infectious Diseases
Centre hospitalier de l’Université de Montréal
MD
Discipline: Public Health/Preventive Medicine
Medical Officer of Health, Central Zone, Government of Alberta
President, Public Health Physicians of Canada
University of Calgary
Calgary, AB
BSc(Pharm), PharmD, ACPR
Discipline:
Pharmacist, Pediatric Infectious Diseases and Antimicrobial Stewardship
McMaster University
Hamilton, ON
Discipline:
Paediatric Infectious Diseases, Antimicrobial Stewardship
Associate Professor, Department of Pediatrics, University of Alberta
Edmonton, AB
MD, CCFP
Université de Montréal
Montreal, QC
AMMI Canada, Executive Director
Methodologist
AMMI Canada Project Coordinator
For further information contact
Riccarda Galioto, Executive Director, AMMI Canada riccarda@ammi.ca
Disclaimer: The views expressed herein do not necessarily represent the views of the Public Health Agency of Canada.
